A Randomized Study of Cervical Priming With Misoprostol Prior to Elective First Trimester Pregnancy Termination
Completed · Phase 2
Conditions studied: Abortion, Therapeutic
In brief
The purpose of this study is to determine whether misoprostol administered prior to elective first trimester pregnancy has an effect on pain and ease of procedure and complications.
Key facts
- Study ID
- NCT00310921
- Run by
- Kaiser Permanente
- People needed
- 200
- Starts
- 2001-05-01
- Expected to finish
- 2006-05-01
- Last updated by the study team
- 2007-04-11
Who can join
Age: any. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Subjects must meet the following inclusion criteria: after completion of a full history and physical exam each subject must be judged physically and mentally stable by the enrolling practitioner; subjects must be between 7 and 11 weeks pregnant and desiring termination. Gestation dating must be based on a reliable menstrual history consistent with a bimanual exam or ultrasound. All subjects must give informed consent after the study has been explained.
You may not qualify if…
- Subject must not have a physical or mental health condition which could be adversely affected by the study drug, including a history of allergy to prostaglandins or, specifically, to misoprostol.
Where it is running
- Kaiser Permanente, Department of OB/GYN — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.